A Single Centre Study Comparing Continuous Interstitial Fluid Lactate Detection to Standard Measurements of Lactate in Patients Undergoing Elective Coronary Artery Bypass Graft Surgery and/or Valve Replacement.

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 20, 2025

Primary Completion Date

November 1, 2025

Study Completion Date

November 1, 2025

Conditions
Coronary Artery BypassCoronary Artery Bypass GraftCoronary Artery Bypass Graft Surgery (CABG)Valve ReplacementValve SurgeryCardiovascularCABG
Interventions
DEVICE

Continuous Lactate Monitoring Device

Continuous interstitial fluid lactate monitoring using the Abbott Investigational Lactate Device.

Trial Locations (1)

Unknown

RECRUITING

Barts Health, London

All Listed Sponsors
lead

Queen Mary University of London

OTHER